View in EDS

Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.

Saved in:
Bibliographic Details
Title: Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.
Authors: Valtis YK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Nemirovsky D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Sharan S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Kabel C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Ortiz R; Department of Medicine, Mount Sinai Morningside-West, New York, NY., Thompson MC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Roeker LE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Geyer MB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Source: Blood advances [Blood Adv] 2024 Nov 26; Vol. 8 (22), pp. 5806-5813.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39121368
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Valtis+YK%22">Valtis YK</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Nemirovsky+D%22">Nemirovsky D</searchLink>; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Derkach+A%22">Derkach A</searchLink>; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Sharan+S%22">Sharan S</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Kabel+C%22">Kabel C</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Ortiz+R%22">Ortiz R</searchLink>; Department of Medicine, Mount Sinai Morningside-West, New York, NY.<br /><searchLink fieldCode="AU" term="%22Thompson+MC%22">Thompson MC</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Roeker+LE%22">Roeker LE</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Geyer+MB%22">Geyer MB</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2024 Nov 26; Vol. 8 (22), pp. 5806-5813.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39121368
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2024013927
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5806
    Titles:
      – TitleFull: Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Valtis YK
      – PersonEntity:
          Name:
            NameFull: Nemirovsky D
      – PersonEntity:
          Name:
            NameFull: Derkach A
      – PersonEntity:
          Name:
            NameFull: Sharan S
      – PersonEntity:
          Name:
            NameFull: Kabel C
      – PersonEntity:
          Name:
            NameFull: Ortiz R
      – PersonEntity:
          Name:
            NameFull: Thompson MC
      – PersonEntity:
          Name:
            NameFull: Roeker LE
      – PersonEntity:
          Name:
            NameFull: Geyer MB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 11
              Text: 2024 Nov 26
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 22
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1